Close X
Friday, October 4, 2024
ADVT 
National

Pfizer to deliver 1M doses, Moderna to catch up

Darpan News Desk The Canadian Press, 12 Apr, 2021 04:39 PM
  • Pfizer to deliver 1M doses, Moderna to catch up

The federal government is expecting Moderna to make good on a previously promised batch of 855,000 COVID-19 vaccine doses that were expected last week, but have yet to arrive.

Those delayed doses along with a little more than one million shots of the Pfizer-BioNTech vaccine represent the extent of Canada’s expected vaccine deliveries this week, even as the number of new COVID-19 cases across Canada continues to surge.

Maj.-Gen. Dany Fortin, the military officer overseeing the federal government’s vaccination distribution effort, blamed the delay in Moderna’s planned delivery on a “backlog with quality assurance."

“It's part of the manufacturing process, at the tail end of the manufacturing process, that they want to go through the proper quality assurance processes, and there's a backlog,” he said last week.

Officials have indicated there could be a similar delay in the delivery of 1.2 million doses from Moderna next week.

“It’s prudent planning on our part right now to bank on the last week of April,” Fortin said.

In comparison, Pfizer-BioNTech has been consistently delivering more than 1 million shots to Canada each week for more than a month, a trend that is expected to continue for the foreseeable future.

The Public Health Agency is not expecting any shots of the Oxford-AstraZeneca vaccine this week. Canada has also approved a vaccine produced by Johnson & Johnson, but it is not clear when the first of those doses will be delivered.

The rush to get vaccines into Canadians' arms has grown more urgent as Canada continues to see a massive spike in the number of new COVID-19 infections.

Tam said many of those getting sick are younger than in previous COVID-19 surges, which experts have blamed on virus variants that are spreading across the country.

That has prompted some provinces to start looking at changes to how they are distributing their vaccines.

More than 10 million doses had been distributed across Canada as of Sunday afternoon, according to covid19tracker.ca, with nearly 8 million having been administered.

Almost 20 per cent of the population has received at least one shot.

MORE National ARTICLES

Air Force flybys help mark Remembrance Day

Air Force flybys help mark Remembrance Day
The Royal Canadian Air Force says it will conduct flybys in several locations across Canada, including four over Vancouver Island and two above Metro Vancouver.

Air Force flybys help mark Remembrance Day

Vertex to bring cystic fibrosis drugs to Canada

Vertex to bring cystic fibrosis drugs to Canada
Cystic Fibrosis Canada and other advocates hailed the development as a triumph in their prolonged campaign to help patients gain access to "life-changing" treatments.

Vertex to bring cystic fibrosis drugs to Canada

Veterans groups to get $20M to weather COVID-19

Veterans groups to get $20M to weather COVID-19
The government first set aside $20 million for veterans groups that provide services to former military personnel in the COVID-19 relief bill passed by Parliament last month.

Veterans groups to get $20M to weather COVID-19

Toronto, Ontario record new COVID-19 record

Toronto, Ontario record new COVID-19 record
Toronto reports 520 new cases of COVID-19 today, after recording 482 new cases Monday. British Columbia reported nearly 1,000 cases Monday, after implementing tougher new restrictions in the Vancouver area over the weekend.

Toronto, Ontario record new COVID-19 record

Man accused in van attack raises NCR defence

Man accused in van attack raises NCR defence
Minassian told a detective just hours after the incident that he carried out the attack as retribution against society because he was a lonely virgin who believed women wouldn't have sex with him.

Man accused in van attack raises NCR defence

Medicago reports promising COVID-19 vaccine tests

Medicago reports promising COVID-19 vaccine tests
Medicago says the side effects were generally mild to moderate and short in duration. The Phase 1 clinical trial was a randomized, partially blinded study of 180 healthy people.

Medicago reports promising COVID-19 vaccine tests